Clinical trial / 2014
Phyllanthus emblica extract reduced cold pressor test-induced changes in arterial stiffness and improved myocardial perfusion index in healthy volunteers.
In a double-blind, placebo-controlled crossover study, 12 healthy volunteers were randomized to receive either two capsules of Phyllanthus emblica extract 250 mg or placebo twice daily for 14 days, followed by a 14-day washout and crossover. Compared with baseline and placebo, P. emblica extract produced a significant decrease of mean percent change in indices of arterial stiffness (augmentation index, radial and aortic blood pressure) and an increase in subendocardial viability ratio with the cold pressor test. Both treatments were well-tolerated with no serious adverse events reported.
- Study type
- Double-blind, placebo-controlled crossover trial
- Who was studied
- 12 healthy human volunteers
- What was measured
- Cardiovascular parameters and aortic wave reflections before and after cold pressor test
THE PAPER
Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects.
Fatima N, Pingali U, Pilli R. Pharmacognosy Res, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.